While heating pads and blankets offer comfort during cold seasons or aid in pain relief, experts warn they can cause a skin ...

Introducing DeepMerkel: a machine-learning model that delivers personalized survival predictions for Merkel cell carcinoma, ...

The FDA has approved the investigational new drug application of 225Ac-SSO110, allowing for the start of a phase 1/2 trial in ...

A machine learning model can make accurate survival predictions for Merkel cell carcinoma (MCC), according to a stu ...

Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announced that the US Food and ...

Ariceum Therapeutics announced that the FDA has cleared its investigational new drug application to commence a Phase I/II ...

Shares of Phio Pharmaceuticals Corp. surged 330% Monday afternoon, reaching their highest levels in nearly eight months, to ...

Phio Pharmaceuticals shares more than tripled after the company said it saw positive results from its Phase 1b trial for its cancer treatment PH-762. Shares were recently up more than 270% to $6.30 in ...

Garching / Munich / Berlin, Germany, January 13, 2025 – (ITM), a leading radiopharmaceutical biotech company, and Ariceum ...

Pathologic Complete Response reported for 2 patients with cutaneous Squamous Cell Carcinoma Marlborough, ...

Researchers at Newcastle University in the UK have developed a groundbreaking tool called “DeepMerkel,” powered by artificial ...